These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9005295)

  • 21. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
    Turner RC; Cull CA; Frighi V; Holman RR
    JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes care: what should we try to achieve?
    O'Connor PJ
    J Fam Pract; 1991 Oct; 33(4):343-4. PubMed ID: 1919448
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of troglitazone in patients with type 2 diabetes mellitus not adequately controlled by sulfonylureas.
    Bunnag P; Puavilai G; Chanprasertyotin S; Chandraprasert S; Suwanwalaikorn S; Suthijumroon A; Benjasuratwong Y; Boonyavarakul A; Nitiyanant W; Sriussadaporn S; Deerochanawong C;
    Diabetes Res Clin Pract; 2001 Feb; 51(2):151-3. PubMed ID: 11253769
    [No Abstract]   [Full Text] [Related]  

  • 24. [Combined insulin and sulfonylurea treatment in diabetes mellitus].
    Ravina A; Minuhin O
    Harefuah; 1986 Jan; 110(1):11-4. PubMed ID: 3514394
    [No Abstract]   [Full Text] [Related]  

  • 25. Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
    Rachman J; Payne MJ; Levy JC; Barrow BA; Holman RR; Turner RC
    Diabetes Care; 1998 May; 21(5):810-6. PubMed ID: 9589246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Will DPP-4 inhibitors replace sulfonylureas in the treatment of type 2 diabetes? Contra].
    Müller UA
    Dtsch Med Wochenschr; 2011 Mar; 136(11):547. PubMed ID: 21351042
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis.
    Gross JL; Kramer CK; Leitão CB; Hawkins N; Viana LV; Schaan BD; Pinto LC; Rodrigues TC; Azevedo MJ;
    Ann Intern Med; 2011 May; 154(10):672-9. PubMed ID: 21576535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tough glucose reduction necessary in newly diagnosed diabetes].
    Rydén M
    Lakartidningen; 2010 Nov 10-16; 107(45):2810-4. PubMed ID: 21179867
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial.
    Yale JF; Valiquett TR; Ghazzi MN; Owens-Grillo JK; Whitcomb RW; Foyt HL
    Ann Intern Med; 2001 May; 134(9 Pt 1):737-45. PubMed ID: 11329231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of glurenorm in patients with non-insulin-dependent diabetes mellitus and liver diseases].
    Dedov II; Demidova IIu; Pisklakov SV; Antokhin EA
    Probl Endokrinol (Mosk); 1993; 39(3):6-8. PubMed ID: 8058688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triple oral anti-diabetic therapy in type 2 diabetes.
    Barnett AH
    Diabet Med; 2003 Jan; 20 Suppl 1():14-6. PubMed ID: 12647835
    [No Abstract]   [Full Text] [Related]  

  • 32. Does the choice of treatment for type 2 diabetes affect the physiological response to hypoglycemia?
    Peacey SR; Robinson R; Bedford C; Harris ND; Macdonald IA; Holman RR; Heller SR
    Diabetes Care; 2000 Jul; 23(7):1022-3. PubMed ID: 10895860
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of type 2 diabetes: a review of metformin in clinical practice.
    Hadley RD; Whaley JW; Askins DG
    J S C Med Assoc; 1998 Jan; 94(1):12-5. PubMed ID: 9473866
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of glycaemic control in patients with diabetes mellitus on insulin therapy.
    Mukherjee JJ; Majumdar S; Ray S
    J Indian Med Assoc; 2013 Nov; 111(11):761-5. PubMed ID: 24968486
    [No Abstract]   [Full Text] [Related]  

  • 35. Effectiveness of sitagliptin compared to sulfonylureas for type 2 diabetes mellitus inadequately controlled on metformin: a systematic review and meta-analysis.
    Sharma M; Beckley N; Nazareth I; Petersen I
    BMJ Open; 2017 Oct; 7(10):e017260. PubMed ID: 29084794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [SGLT-2-inhibitor dapagliflozin: new treatment approach for diabetes type 2--new achievements, but also new questions!].
    Nauck M; Del Prato S
    Dtsch Med Wochenschr; 2013 Apr; 138 Suppl 1():S4-5. PubMed ID: 23529569
    [No Abstract]   [Full Text] [Related]  

  • 37. How long can insulin therapy be avoided in the patient with type 2 diabetes mellitus by use of a combination of metformin and a sulfonylurea?
    Bell DS; Ovalle F
    Endocr Pract; 2000; 6(4):293-5. PubMed ID: 11242605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between acarbose, metformin, and insulin treatment in type 2 diabetic patients with secondary failure to sulfonylurea treatment.
    Calle-Pascual AL; Garcia-Honduvilla J; Martin-Alvarez PJ; Vara E; Calle JR; Munguira ME; Marañes JP
    Diabete Metab; 1995 Oct; 21(4):256-60. PubMed ID: 8529760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Home glucose monitoring makes little difference in type 2 diabetes.
    J Fam Pract; 2005 Nov; 54(11):936. PubMed ID: 16299946
    [No Abstract]   [Full Text] [Related]  

  • 40. [Diabetic complications: good metabolic control protects].
    MMW Fortschr Med; 2011 Apr; 153(15):44-5. PubMed ID: 21667560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.